Truelove and Witts Severity Index for Ulcerative Colitis
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Mild—
- Moderate—
- Severe—
The Truelove and Witts Severity Index for Ulcerative Colitis calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include bowel movements. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Stratifies severity of ulcerative colitis into mild, moderate, or severe categories based on clinical and laboratory parameters
Clinical Indication
The Truelove and Witts Severity Index for Ulcerative Colitis is indicated for bedside clinical practice to support Stratifies severity of ulcerative colitis into mild, moderate, or severe categories based on clinical and laboratory parameters. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.
Classification based on presence of criteria: Mild = all criteria for mild severity met (bowel movements <4, no/small blood, no fever, pulse ≤90, no anemia, ESR ≤30); Severe = ≥6 bowel movements AND ≥1 systemic feature (fever, tachycardia, anemia); Moderate = between mild and severe criteria
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| bowel_movements | string | Yes | Number of bowel movements per day |
| blood_in_stool | string | Yes | Presence and severity of blood in stool |
| pyrexia | string | Yes | Presence of fever (temperature ≥100.04°F or 37.8°C) |
| tachycardia | string | Yes | Pulse greater than 90 beats per minute |
| anemia | string | Yes | Presence of anemia (hemoglobin ≤10.5 g/dL or 105 g/L) |
| esr_elevated | string | Yes | Erythrocyte sedimentation rate greater than 30 mm/hr |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | Mild | Mild ulcerative colitis |
| — | Moderate | Moderate ulcerative colitis |
| — | Severe | Severe ulcerative colitis |
Evidence-Based References (EBM)
- Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041-8. PMID: 13260656; PMCID: PMC2061071.PMID: 13260656
- Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011 Nov 3;365(18):1713-25. doi: 10.1056/NEJMra1102942.DOI: 10.1056/NEJMra1102942
- Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.DOI: 10.14309/ajg.0000000000000152